At Factor Bioscience, our goal is to unleash the potential of mRNA to treat disease and improve health. We are developing cutting-edge mRNA medicines, including mRNA-based reprogramming and gene editing medicines for anti-inflammatory, anti-cancer, and regenerative-medicine applications. We support multiple active collaborations with university and industry partners to develop and deploy new therapies using our large and growing portfolio of RNA technologies.